We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
-4.29%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.92B
AUM Growth
-$64.5M
(-3.2%)
Cap. Flow
+$89.8M
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
1,008
New
367
Increased
112
Reduced
107
Closed
328
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$23.7M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$11.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$7.54M |
| 4 |
Marathon Petroleum
MPC
|
+$6.85M |
| 5 |
Planet Fitness
PLNT
|
+$5.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$8.44M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$6.21M |
| 3 |
Twilio
TWLO
|
+$6M |
| 4 |
Agnico Eagle Mines
AEM
|
+$5.39M |
| 5 |
O'Reilly Automotive
ORLY
|
+$5.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.59% |
| 2 | Consumer Discretionary | 2.4% |
| 3 | Energy | 2.06% |
| 4 | Financials | 1.79% |
| 5 | Technology | 1.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Centene
CNC
$30B
| $6.52M | 0.34% |
150,800
-55,800
| -27% | -$2.72M |
|
77
PUT
Agios Pharmaceuticals
AGIO
$1.89B
| $6.51M | 0.34% |
+201,000
| New | +$8.32M |
|
|
MRTX
78
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.47M | 0.34% |
83,100
-174,100
| -68% | -$16.3M |
|
79
PUT
Fidelity National Information Services
FIS
$23.4B
| $6.42M | 0.33% |
+48,400
| New | +$6.43M |
|
80
CALL
Dell
DELL
$264B
| $6.38M | 0.33% |
+242,876
| New | +$6.44M |
|
|
81
PUT
Dell
DELL
$264B
| $6.38M | 0.33% |
+242,876
| New | +$6.44M |
|
|
SAGE
82
PUT
DELISTED
Sage Therapeutics
SAGE
| $6.38M | 0.33% |
45,500
+8,000
| +21% | +$1.34M |
|
83
PUT
Delek US
DK
$4.16B
| $6.33M | 0.33% |
174,300
-4,200
| -2% | -$155K |
|
84
PUT
RingCentral
RNG
$4.63B
| $6.28M | 0.33% |
+50,000
| New | +$6.56M |
|
85
CALL
DaVita
DVA
$15.3B
| $6.21M | 0.32% |
108,900
-72,700
| -40% | -$4.22M |
|
|
UNIT
86
PUT
Uniti Group
UNIT
$2.29B
| $6.1M | 0.32% |
785,200
+26,500
| +3% | +$220K |
|
87
CALL
Marriott International
MAR
$98.7B
| $6.04M | 0.31% |
48,600
-1,400
| -3% | -$186K |
|
|
ALDR
88
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
| $6.02M | 0.31% |
+319,300
| New | +$3.65M |
|
|
ITCI
89
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6M | 0.31% |
803,100
+481,400
| +150% | +$4.62M |
|
90
CALL
Iovance Biotherapeutics
IOVA
$1.95B
| $5.88M | 0.31% |
323,200
+293,200
| +977% | +$6.48M |
|
91
CALL
VanEck Oil Services ETF
OIH
$2.03B
| $5.88M | 0.31% |
25,000
| – | – |
|
|
WW
92
CALL
DELISTED
WW International
WW
| $5.86M | 0.31% |
155,000
| – | – |
|
|
MRTX
93
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.71M | 0.3% |
73,200
+62,000
| +554% | +$5.82M |
|
94
CALL
Axsome Therapeutics
AXSM
$11.5B
| $5.67M | 0.3% |
280,400
+215,400
| +331% | +$5.53M |
|
95
CALL
Sarepta Therapeutics
SRPT
$1.61B
| $5.65M | 0.29% |
75,000
-2,900
| -4% | -$342K |
|
96
PUT
Bath & Body Works
BBWI
$3.97B
| $5.55M | 0.29% |
+350,566
| New | +$6.19M |
|
97
CALL
Adient
ADNT
$1.62B
| $5.53M | 0.29% |
240,800
+63,000
| +35% | +$1.44M |
|
98
CALL
RH
RH
$3.15B
| $5.38M | 0.28% |
31,500
| – | – |
|
99
PUT
Papa John's
PZZA
$991M
| $5.24M | 0.27% |
+100,000
| New | +$4.71M |
|
100
CALL
Marvell Technology
MRVL
$171B
| $4.99M | 0.26% |
+200,000
| New | +$5.02M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q3 2019 Portfolio in Review
As of Q3 2019, Caption Management held 1,008 positions worth $1.92B, down 3.2% from $1.99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Caption Management deployed $89.8M of net new capital in Q3 2019, opening 367 new positions and adding to 112 existing holdings. Its largest new stake was PayPal: 215,000 shares worth $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 4.6% of assets, up from 3% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $6.21M trimmed.
- Caption Management's largest Q3 2019 buy was PayPal: 215,000 shares worth $22.3M.
- Caption Management added most to Medicines Co in Q3 2019, an estimated $7.54M increase.
- Caption Management's biggest Q3 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $6.21M.
- Caption Management fully exited Upbound Group in Q3 2019, selling an estimated $8.44M.
- Caption Management's ten largest holdings make up 15% of its $1.92B portfolio in Q3 2019.
- Caption Management opened 367 new positions and closed 328 in Q3 2019.
- Caption Management's portfolio value fell 3.2% quarter-over-quarter to $1.92B.
Based on Caption Management's 13F filing for Q3 2019, filed 14 Nov 2019.